RXO (NYSE: RXO) today reported its third-quarter financial results. RXO Chairman and CEO Drew Wilkerson said, "Market ...

U.S. net product revenue for the three and nine months ended September 30, 2025 was $40.7 million and $115.8 million, respectively, compared to $31.1 million and $84.2 million, for the comparable ...

To highlight logic of normal patient “selection,” Gelly blends the data from her sociology dissertation, completed in the ...